We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Study Could Harm Industry's Bottom Line, Spur Changes
Study Could Harm Industry's Bottom Line, Spur Changes
September 27, 2006
The IOM report on the FDA’s drug safety practices could do long-term damage to industry revenue and will likely spur legislation in the next Congress, sources say.